Description：Rabbit polyclonal antibody to PKR (Phospho-T451)Immunogen：KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding T451 of human PKR protein. The exact sequence is proprietary.Purification：The antibody was purified by immunogen affinity chromatography.Clonality：PolyclonalForm：Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution：WB (1/500 - 1/1000), IH (1/100 - 1/200)Gene Symbol：EIF2AK2Alternative Names：PKR; PRKR; Interferon-induced, double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2; Interferon-inducible RNA-dependent protein kinase; P1/eIF-2A protein kinase; Protein kinase RNA-activated; PKR; Tyrosine-protein kinase EIF2AK2; p68 kinase Entrez Gene (Human)： 5610; Entrez Gene (Mouse)： 19106; SwissProt (Human)： P19525; SwissProt (Mouse)： Q03963; Storage/Stability：Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

• 
  Western blot analysis of PKR (Phospho-T451) expression in HeLa PMA-treated (A), Raw264.7 H2O2-treated (B), NIH3T3 LPS-treated (C) whole cell lysates. (Predicted band size: 62 kD; Observed band size: 62 kD)
• 
  Immunohistochemical analysis of PKR (Phospho-T451) staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
• 
  Direct ELISA antibody dose-response curve using Anti-PKR (Phospho-T451) Antibody. Antigen (Phosphopeptide and non-phosphopeptide) concentration is 5 ug/ml. Goat Anti-Rabbit IgG (H&L) - HRP was used as the secondary antibody, and signal was developed by TMB substrate.